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Extensive studies have demonstrated that oxidative stress plays a vital role in the pathology of several neurological diseases,
including autism spectrum disorder (ASD); those studies proposed that GSH and antioxidant enzymes have a pathophysiological
roleinautism.Furthermore,camelmilkhasemergedtohavepotentialtherapeuticeffectsinautism.Theaimofthecurrentstudywas
toevaluatetheeffectofcamelmilkconsumptiononoxidativestressbiomarkersinautisticchildren,bymeasuringtheplasmalevels
of glutathione, superoxide dismutase, and myeloperoxidase before and 2 weeks after camel milk consumption, using the ELISA
technique. All measured parameters exhibited significant increase after camel milk consumption (𝑃 < 0.5). These findings suggest
that camel milk could play an important role in decreasing oxidative stress by alteration of antioxidant enzymes and nonenzymatic
antioxidantmoleculeslevels,aswellastheimprovementofautisticbehaviourasdemonstratedbytheimprovedChildhoodAutism
Rating Scale (CARS).
1. Introduction
Autism spectrum disorder (ASD) is a severe neurodevel-
opment disorder with onset prior to 3 years of age [1, 2].
It is characterized by impairments in social orientation,
communication,andrepetitivebehaviors[3,4].Inadditionto
behavioural impairment, ASD is associated with high preva-
lence of autoimmune disease [5, 6], gastrointestinal disease
and dysbiosis [7], and mental retardation [8].
The prevalence of autism has increased over the last
several decades. The incidence of ASD in United States
increased in 2008 to 1 in 88 children [9]. Prevalence of
autism spectrum disorders in Saudi Arabia is estimated to be
6:1000 [10]. Increased prevalence has great effects on public
health implications and has stimulated intense research into
potential etiologic factors.
Although the aetiology and pathology is poorly under-
stood, different factors have been suggested to affect autism,
forexample,immunefactors,environmental,neurochemical,
and genetic factors [3, 10, 11], oxidative stress [10–13].
Extensive studies have demonstrated that oxidative stress
plays a vital role in the pathology of several neurological
diseases such as Alzheimer’s disease [14], Down syndrome
[15], Parkinson’s disease [16], schizophrenia [17], bipolar
disorder [18], and autism [10, 14].
Oxidative stress occurs when reactive oxygen species
(ROS) levels exceed the antioxidant capacity of a cell. It acts
as a mediator in brain injury, strokes, and neurodegenerative
diseases[19–21];thus,thecontrolofROSproductionisneces-
saryforphysiologiccellfunction.TheROSwithinthecellsare
neutralized by antioxidant defence mechanisms, including
superoxide dismutase (SOD), catalase, and glutathione per-
oxidise(GSH-Px)enzymes.TheincreasedproductionofROS
both centrally (in the brain) and peripherally (in the plasma)
may result in the reduction of brain cell number leading to
autism pathology and apoptosis [14, 22].2 Evidence-Based Complementary and Alternative Medicine
Several studies have suggested the contribution of oxida-
tive stress to the development of autism. These studies
demonstrated the alteration of antioxidant enzymes like
GSH-Px, MPO, and SOD, lipid peroxidation, antioxidant
proteins as ceruloplasmin and transferrin, and detoxifying
metaboliteslikeGSH,aswellasantioxidantnutrientvitamins
and minerals [10, 11, 13, 23–26].
Camel milk has emerged to have potential therapeutic
effectsinmanydiseasessuchasfoodallergy,diabetesmellitus
[27, 28], hepatitisB [29], autism [30], and other autoimmune
diseases [31]. It has a unique composition that differs from
other ruminants’ milk. It contains lower fat, cholesterol,
and lactose than cow milk, higher minerals (calcium, iron,
magnesium, copper, zinc, and potassium) and vitamins A,
B2, E, and C compared to cow milk [32, 33], and it con-
tains no beta lactoglobulin and beta casein which are the
main causative of allergy in cow’s milk [34]. Furthermore,
camel milk contains various protective proteins, mainly
enzymes which exert antibacterial, antiviral, and immuno-
logical properties [35, 36]; these include immunoglob-
ulins, lysozymes, lactoferrin, lactoperoxidase, N-acetyl-§-
glucosaminidase (NAGase), and peptidoglycan recognition
protein (PGRP) [34], which are crucial in preventing food
allergy and rehabilitating the immune system [31]. Camel
milk proved its potential effect in the treatment of food aller-
gies,duetoitsinflammation-inhibitingproteins,andhypoal-
lergenicproperties,inadditiontoitssmallersizenanobodies,
which are different than those found in human. Camel
milk nanobodies, as a single domain, show many promis-
ing and therapeutic potencies in infection and immunity
[37].
Th ea i mo ft h ec u r r e n ts t u d yw a st oe v a l u a t et h ee ff e c t
of camel milk consumption on oxidative stress biomarkers
in autistic children, by measuring the plasma levels of
glutathione, superoxide dismutase, and myeloperoxidase.
2. Materials and Methods
2.1. Subjects. The present study included 60 subjects with
ASD, especially those with known allergies or food intol-
erances, aged 2–12 years. Clinical diagnosis was based on
the criteria for autistic disorder as defined in the Diagnostic
and Statistical Manual of Mental Disorders, Fourth Edition,
TextRevision(DSM-IV)[2].Subjectswererecruitedfromthe
Autism Research and Treatment Center, Faculty of Medicine,
King Saud University.
The study protocol received the ethical approval from the
InstitutionalReviewBoardofFacultyofMedicine,KingSaud
University.Awritteninformedconsentwasobtainedfromall
parents/guardians before being enrolled in the study.
2.2. Study Design. The study was a double-blinded, random-
ized clinical trial (RCT). The participants were randomly
divided into three groups: Group I (𝑛=2 4 )r e c e i v e dr a w
camel milk; Group II (𝑛=2 5 )r e c e i v e db o i l e dc a m e lm i l k ;
and Group III (𝑛=1 1 ) received cow milk as a placebo. All
groups received the same instructions, volume of milk, and
containers to preserve the blinding of the study.
Parents were instructed to include the average of 500mL
of camel milk in their children’s regular daily diet for a
period of 2 weeks. Parents were asked to continue with the
children’s daily routines. They were not allowed to add or
remove any interventions such as diet plans, supplements,
or pharmacotherapies throughout the study period. Group I
was also instructed to drink cold milk, beginning with small
quantities that increase gradually, until 500 mL per day was
consumed to avoid any risk of diarrhoea.
2.3. Childhood Autism Rating Scale (CARS). The Childhood
Autism Rating Scale (CARS) was administered as a measure
ofsymptomseverity[11].TheWingSubgroupsQuestionnaire
(WSQ) [12] is a questionnaire with 13 behavioral domains
(e.g.,communication,socialapproach,play,imitation,motor
behavior, and resistance to change) on which parents rate
their child’s behavior. A summary score is calculated for each
subtype (i.e., aloof, passive, and active but odd), and the
highest summary score is considered to indicate the subtype.
2.4. Blood Sampling. After overnight fast, ten mL blood
samples were collected in EDTA tubes from autistic children
before and 2 weeks after camel milk consumption. Centrifu-
gation was done; plasma and red blood cells were obtained
a n dd e e pf r o z e n( a t−80
∘C) until further analysis.
2.5. Methods
2.5.1. Measurement of Glutathione. This was done by using
commercially available ELISA kit (Wuhan Eiaab Science
Inc., China) specific for measurement of plasma glutathione
levels according to the manufacturer’s instructions. Briefly,
the microtiter plate has been precoated with an antibody
specifictoGSH.Standardsandsampleswerepipettedintothe
wells with a biotin-conjugated polyclonal antibody specific
for GSH. Next, avidin conjugated to horseradish peroxidase
(HRP) was added and incubated. A substrate solution was
a d d e da n dc o l o u rd e v e l o p e di np r o p o r t i o nt ot h ea m o u n to f
GSH. Thecolourdevelopmentwas stopped, andtheintensity
of the colour was measured.
2.5.2. Measurement of Superoxide Dismutase. This assay
employs the quantitative sandwich enzyme immunoassay
techniquefortheassessmentofhumansuperoxidedismutase
in plasma (Wuhan Eiaab Science Inc., China). A mono-
clonal antibody specific for SOD has been precoated onto
a microplate. Standards and samples were pipetted into the
wells, followed by addition of a second antibody specific for
SOD. Then, a substrate solution was added to the wells and
colourdevelopedinproportiontotheamountofSODbound
i nt h ei n i t i a ls t e p .Th ec o l o u rd e v e l o p m e n tw a ss t o p p e d ,a n d
the intensity of the color was measured.
2.5.3.MeasurementofMyeloperoxidase. Plasmamyeloperox-
idase level was measured using double antibody sandwich
ELISA (GenWay biotech, USA) according to the manufac-
turer’s instructions. This method is based upon formation of
enzyme-labeled antibodies complex followed by addition ofEvidence-Based Complementary and Alternative Medicine 3
Table1:Glutathione,superoxidedismutase,andmyeloperoxidaseinplasmaofautisticchildrentogetherwithCARSbeforeand2weeksafter
camel milk consumption.
Raw milk (𝑁=2 4 ) Boiled milk (𝑁=2 5 ) Placebo (𝑁=1 1 )
Mean ± SEM 𝑃 value Mean ± SEM 𝑃 value Mean ± SEM 𝑃 value
Glutathione
Before 0.37 ± 0.03 0.05 0.34 ± 0.03 0.02 0.36 ± 0.02 0.5
After 0.41 ± 0.01 0.45 ± 0.02 0.35 ± 0.04
SOD
Before 0.54 ± 0.03 0.2 0.49 ± 0.02 0.007 0.52 ± 0.03 0.5
After 0.59 ± 0.02 0.57 ± 0.02 0.54 ± 0.03
MPO
Before 2.65 ± 0.17 0.05 2.44 ± 0.13 0.02 2.11 ± 0.37 0.2
After 3.22 ± 0.24 3.08 ± 0.19 2.62 ± 0.16
CARS
Before 37.63 ± 6.31 0.004 36.82 ± 3.27 0.001 34.18 ± 3.25 0.772
After 34.54 ± 5.19 33.80 ± 4.91 34.41 ± 3.25
chromogenic substrate to develop a color that is proportion-
a t et ot h em y e l o p e r o x i d a s ec o n c e n t r a t i o n .
2.6. Statistical Analysis. The data were analyzed and pre-
sented as mean ± SEM (standard error of the mean). Statisti-
cal differences in each measurement before and 2 weeks after
milktherapyweredeterminedwith𝑃values,and𝑃 < 0.5was
considered significant. The receiver operating characteristics
(ROC)curveasafundamentaltoolforbiomarkersevaluation
was performed using the same computer program. In a ROC
curve,thetruepositiverate(sensitivity)isplottedinfunction
of the false positive rate (100-specificity) for different cut-
off points of a parameter. Each point on the ROC curve
represents a sensitivity/specificity pair corresponding to a
particular decision threshold. The area under the ROC curve
isameasureofhowwellaparametercandistinguishbetween
camel-milk-treated and untreated autistic subjects.
3. Results
The present study was performed to study the effect of
camel milk consumption on oxidative stress on ASD subjects
by measuring the plasma levels of glutathione, superoxide
dismutase, and myeloperoxidase.
Table 1 and Figure 1 show plasma levels of GSH, SOD,
and MPO together with CARS of autistic children, before
and 2 weeks after camel milk consumption. All measured
parameters showed significant changes after camel milk
consumption.
PlasmaGSHlevelsweresignificantlyincreasedingroupI
and group II (𝑃 = 0.05, 𝑃 = 0.02, resp.), but not in group III,
following 2 weeks of camel milk consumption. In addition,
plasmalevelsofSODdemonstratednosignificantdifferences
in group I (𝑃 = 0.2) and group III (𝑃 = 0.5). On the other
hand, group II demonstrated a highly statistically significant
change following 2 weeks of boiled camel milk consumption
(𝑃 = 0.007). Furthermore, there was a significant elevation
o fM P Oi nb o t hg r o u pI ,t h er a wc a m e lm i l k( 𝑃 = 0.05), and
group II, the boiled camel milk (𝑃 = 0.02), but not in group
III, the placebo group (𝑃=0 . 2 ).
Table 2 and Figures 2(a)–2(d) demonstrate ROC analysis
of the 4 measured variants. It could be easily noticed that
GSH, SOD, MPO, and CARS show higher area under the
c u r v e( A U C ) ,%s p e c i fi c i t y ,a n ds e n s i t i v i t yi ng r o u p sIa n dI I
than in group III.
4. Discussion
Thepresentstudyaimedatevaluatingtheeffectofcamelmilk
on oxidative stress among subjects with autism spectrum
disorders by measuring the levels of antioxidant enzymes:
SOD, MPO, and GSH.
Several studies have suggested an increased vulnera-
bility of subjects with ASD to oxidative stress. Oxidative
stress and the consequent damage occur when antioxidant
defencemechanismsfailtoeffectivelycounterendogenousor
exogenous sources of reactive oxygen species [38]. Increased
oxidative stress might contribute to behavioural aberrations,
sleep disorder, and gastrointestinal disturbances in autistic
children [39, 40].
Low plasma antioxidant enzymes, GSH-Px [25]a n d
SOD [23], were reported. Low level of antioxidant enzymes
indicated increased vulnerability to oxidative stress due to
impaired antioxidant defence mechanisms, which lead to
harmful effects of free radicals that could have an important
role in theaetiologyof autism.Moreover,increasedoxidative
stress in autistic subjects leads to a decrease in the levels of
nonenzymatic antioxidants like GSH, vitamin E and C [13],
whichinturnleadstoimpairmentofmetabolicpathwaysand
may contribute to the developmental delays which occur in
autism; this could be corrected by micronutrient supplemen-
tation[41].Inaddition,lowerplasmalevelsofglutathioneand
cysteine in subjects with ASD were documented [42, 43].
C a m e lm i l kh a sb e e nr e p o r t e dt oi m p r o v ec l i n i c a lo u t -
comes of ASD [31]. The effect of camel milk consumption
on autistic behaviour was documented through significant
changes in the Childhood Autism Rating Scale (CARS)
scoring results [44], as casein- and gluten-free diet has
been reported to improve autistic behavior [31], possibly by
reducing excess central opioid effects [45].4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Levels of (a) GSH, (b) SOD, (c) MPO, and (d) CARS in autistic patients before and after treating with the camel milk. The mean
value for each group is designated by a line.
Table 2: ROC curve of GSH, SOD, MPO, and CARS of autistic patients before and after treatment with camel milk.
Parameters Raw camel milk Boiled Camel milk Placebo
GSH
Area under the curve 0.677 0.723 0.504
Best cut-off value 0.357 0.356 0.326
Sensitivity% 83.3 88.0 45.5
Specificity% 62.5 72.0 72.7
SOD
Area under the curve 0.642 0.706 0.591
Best cut-off value 0.453 0.562 0.585
Sensitivity% 95.8% 56.0% 54.5
Specificity% 41.7% 88.0% 72.7
MPO
Area under the curve 0.584 0.703 0.702
Best cut-off value 3.17 2.385 2.180
Sensitivity% 45.8% 76.0% 90.9%
Specificity% 79.2% 64.0% 54.4%
CARS
Area under the curve 0.729 0.682 0.512
Best cut-off value 35.5 33.75 37.25
Sensitivity% 70.8 44.0 81.8
Specificity% 70.8 96.0 36.4
Glutathione is one of the most important intracellu-
lar antioxidants, responsible for maintaining the reducing
intracellular microenvironment that is essential for normal
cellular function and viability. It also exerts neuroprotective
properties and reduces neuropathy and hence decreases
oxidative stress.
Subjects with ASD were shown to exhibit abnor-
mal plasma levels of metabolites in the pathway of glu-
tathione redox metabolism, due to inefficient detoxifica-
tion system [12]. The concentration of reduced glutathione
(GSH) was found to be significantly decreased compared
to control [10, 25], which reflects increased oxidativeEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: ((a)–(d)): ROC curves showing specificity, sensitivity, and area under the curves for (a) GSH, (b) SOD, (c) MPO, and (d) CARS.6 Evidence-Based Complementary and Alternative Medicine
stress due to the impaired defense mechanisms against
ROS.
Theresultsofthepresentstudyshowasignificantincrease
in GSH level after camel milk consumption; this could be
attributed to the antioxidant nutrients constituents of camel
milk. Magnesium is known to reduce oxidative stress and
enhance vitamin E and C absorption [44], whereas zinc
increases total glutathione, GSHPx, and SOD levels. More-
over, vitamin E has been suggested to enhance glutathione
levels [46]. Taken together, high levels of Mg and Zn and
vitamin E in camel milk might help to increase glutathione
production and enzymes production and hence to decrease
the oxidative stress in autistic subjects.
Superoxide dismutase is an antioxidant enzyme that
inhibits lipid peroxidation by catalyzing the conversion of
superoxide into hydrogen peroxide (H2O2)a n do x y g e n
(O2)[ 13] and acts as a primary defence, as it prevents
further generation of free radicals. Insufficient capacity of
SOD to metabolize the resulting H2O2 may lead to toxicity
[10].
It was shown that the SOD activity was significantly
higher in autistic children compared to control, in response
to oxidative stress. The increased activity may be an adap-
tive response to eliminate superoxide that was excessively
produced [10]. In contrast, other studies reported significant
decrease of SOD levels in autistic children compared to
controls [24, 43], due to the impairment of the defence
mechanism against oxidative stress. Low SOD may also
contribute to the nutritional status as some of the antioxidant
nutrient levels affect the status of the antioxidant enzymes.
For example, adequate amounts of superoxide dismutase
are produced when the body receives an adequate and
balanced intake of copper and zinc. Copper deficiency was
reported to reduce the level of superoxide dismutase [23,46],
whereas zinc deficient diet decreases superoxide dismutase,
glutathioneperoxidase,totalglutathione,andvitaminE[47].
Other studies suggested that the low zinc levels have been
associated with autism and related to lower SOD levels, due
tothelowerzinctocopperratioinautisticchildrencompared
to controls [23, 48].
Inthepresentstudy,SODlevelwassignificantlyincreased
after camel milk consumption; this could be attributed to the
high contents of zinc, copper, magnesium, and vitamin E in
camel milk.
Myeloperoxidase is a biomarker of oxidative stress that is
responsible for microbicidal activity against a wide range of
organisms and one of the indicators of inflammation [49].
Elevated superoxide generated from dysfunctional mito-
chondria promotes the formation of excessive H2O2,t h e
substrate for MPO-mediated hypochlorous acid synthesis,
which is then converted to the inflammatory biomarker, 3-
chlorotyrosine (3-CT), in activated immune cells during an
inflammatory response [38].
Elevated expression of MPO has previously been demon-
strated in chronic neurological disease states, such as
Alzheimer’s disease [50], Parkinson’s disease [51], multiple
sclerosis [52], and autism spectrum disorder [53].
It has been demonstrated that autistic children with
severe GI disease have low serum levels of MPO, which is
directly linked with GI pathology seen in this group [54].
The present study demonstrated a significant increase in
the plasma myeloperoxidase level following camel milk con-
sumption, which could be a consequence of increased level
of SOD. MPO and SOD work synergistically to protect the
cell contents against oxidizing activity by destroying anions
and hydrogen peroxide [50]; superoxide dismutase catalyzes
the conversion of superoxide radicals to H2O2,w i t hc a t a l a s e
neutralizing H2O2 a n dt h e nm y e l o p e r o x i d a s ec o n v e r t i n g
H2O2 to highly reactive hypochlorous acid [23]. Another
possibility might be the improvement of GI problems due to
the deprivation of camel milk from beta lactoglobulin and
beta casein, the major cause for food allergy and GI disease
in autistic subjects [7, 54, 55].
Variousstudiesdemonstratedaremarkableimprovement
of some symptoms in ASD subjects following a gluten-
and casein- free diet [34], glutathione supplementation [22],
antioxidant supplementation such as vitamin E, C, and
selinum [22–24], or magnesium and zinc supplementation
[43]. These molecules are essential for glutathione synthesis,
antioxidant enzymes activities, antioxidant vitamins absorp-
tion,andeffectiveantioxidantdefencemechanismandhence
they play an important role in decreasing oxidative stress as
confirmed in various studies.
In light of this information, the role of camel milk in
decreasing oxidative stress and treatment of ASD could
be explained on the basis that it contains high level of
antioxidant vitamins C, A, and E and is very rich in antiox-
idant minerals magnesium and zinc. Antioxidant vitamins
a r eu s e f u li nr e d u c i n gt h eo x i d a t i v es t r e s s .V i t a m i nEa n d
magnesium have been suggested to enhance glutathione
biosynthesis.Magnesiumdeficiencyhasbeenassociatedwith
the production of reactive oxygen species [46]. On the other
hand, zinc is essential for the activity of many enzymes in
living organisms such as SOD and GPx. It has been reported
that zinc can prevent cell damage through activation of the
antioxidant system [47, 56]. Taken together, these nutrients
enhance the production of detoxifying molecules, absorp-
tion of antioxidant vitamins, and activation of antioxidant
enzymeswhichinturnactivatethedetoxificationsystemand
reduce the exerted oxidative stress. Another possibility is
that camel milk can help to combat and treat gastrointestinal
problems, which are frequently associated with ASD, due to
its inflammation-inhibiting constituents and hypoallergenic
properties,inadditiontoitssmallersizeantibodieswhichare
similar to human antibodies [7, 37], and thus improve some
autistic behaviours.
The role of the measured parameters in the etiology of
autistic features could be also ascertained in this study. The
amelioration induced by raw and camel milk on GSH, SOD,
and MPO was accompanied by a significant improvement in
thebehaviouroftheautisticchildrenaftertwoweeksofcamel
milk consumption. CARS was significantly lower after camel
milk consumption than before.
Table 2 and Figures 2(a)–2(d) demonstrate that although
the four measured parameters did not show very high
specificity and sensitivity, GSH and CARS show satisfactory
values of both measures. This could help to suggest GSH as
a predictive biomarker to follow the potency of camel milkEvidence-Based Complementary and Alternative Medicine 7
treatment in parallel with the measurement of CARS as a
behavioural and cognitional measure.
In conclusion, our findings suggest that camel milk
could play an important role in decreasing oxidative stress
by alteration of antioxidant enzymes and nonenzymatic
antioxidant molecules levels and improvement of autistic
behaviour. A larger scale study considering the period and
dosage of camel milk is needed to determine the effect of
camel milk on oxidative stress biomarkers and hence the
treatmentofASD.Inaddition,otherparametersrepresenting
different signalling pathways related to the pathology of
autism are recommended. Screening for a predictive marker
which might record higher specificity and sensitivity than
those of the present study is critically needed.
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